IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian Halcyon machine in Europe to go clinical, at the hospital UZ Leuven in Belgium, using IBA Dosimetry’s Blue Phantom water phantom system.

January 2, 2018 — A new study found women who had received chemotherapy and/or radiation therapy to treat breast cancer were more likely to have high levels of DNA damage and reduced activity of an enzyme involved in chromosome healing, compared to women who underwent surgery alone.

December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR Appropriateness Criteria.

Migraine sufferers have significantly higher sodium concentrations in their cerebrospinal fluid than people without the condition, according to the first study to use sodium magnetic resonance imaging (MRI) to look at migraine patients. The findings were presented at the annual meeting of the Radiological Society of North America (RSNA), Nov. 26-Dec. 1 in Chicago.

December 28, 2017 — At the 2017 Radiological Society of North America (RSNA) Annual Meeting, Nov. 26-Dec. 1 in Chicago, Thales unveiled the latest Pixium Portable 3543 DR (digital radiography), what it calls the first truly standalone device with Embedded Patient Identification working in auto-detection mode without connection to any external device.

Pixium Portable 3543 DR

December 28, 2017 — Double Black Imaging and their Image Systems Division are releasing their Gemini Series 6MP and 8MP large format LED backlit flat panel display solutions. The Gemini Series Color LED backlit displays double the resolution and eliminate the gap between screens in a multi-head display configuration. Allowing the eye to seamlessly glide between images uninterrupted increases efficiency and improves productivity.

In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the first large-scale longitudinal imaging study to evaluate BACE1 inhibition with micro-PET (positron emission tomography) in mouse models of Alzheimer’s disease. PET imaging has been established as an excellent identifier of the amyloid plaque and tau tangles that characterize Alzheimer’s disease. Now it is proving to be an effective way to gauge treatment effectiveness.

HeartFlow Inc. announced that Health Care Service Corp. (HCSC), which operates Blue Cross and Blue Shield plans in five states, has issued a medical policy for the HeartFlow FFRct Analysis, a non-invasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD). HCSC — which operates Blue Cross Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma and Texas — has determined that the use of noninvasive fractional flow reserve (FFR) following a positive coronary computed tomography (CT) angiogram may be considered medically necessary to guide decisions about the use of invasive coronary angiography in patients with stable chest pain at intermediate risk of CAD.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now